Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant <em>Enterobacterales</em>

• Main Authors: Antonio Vena (Author), Daniele Roberto Giacobbe (Author), Nadia Castaldo (Author), Annamaria Cattelan (Author), Cristina Mussini (Author), Roberto Luzzati (Author), Francesco Giuseppe De Rosa (Author), Filippo Del Puente (Author), Claudio Maria Mastroianni (Author), Antonio Cascio (Author), Sergio Carbonara (Author), Alessandro Capone (Author), Silvia Boni (Author), Chiara Sepulcri (Author), Marianna Meschiari (Author), Francesca Raumer (Author), Alessandra Oliva (Author), Silvia Corcione (Author), Matteo Bassetti (Author), for the Ceftabuse Study Group (Author)
• Formato: Libro
• Publicado: MDPI AG, 2020-02-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background: Experience in real clinical practice with ceftazidime-avibactam for the treatment of serious infections due to gram−negative bacteria (GNB) other than carbapenem-resistant <i>Enterobacterales</i> (CRE) is very limited. Methods: We carried out a retrospective multicenter study...